Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
61
datasets available to search
ShareScore release 0.9.0
Dataset results
61 results for “Lutetium”
Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT05613894. IPD Sharing: NO. Countries: 1. Publications: 0.
HEAT Trial (HER2 Antibody Therapy With Lutetium-177)
ClinicalTrials.gov study NCT06824155. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
ClinicalTrials.gov study NCT05687123. IPD Sharing: YES. Countries: 2. Publications: 0.
A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours
ClinicalTrials.gov study NCT01876771. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia
ClinicalTrials.gov study NCT00005808. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Role of WB-MRI in the Evaluation of Prostate Cancer Patients Treated With Lutetium - Prostate Specific Membrane Antigen (Lu-PSMA)
ClinicalTrials.gov study NCT05208229. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
ClinicalTrials.gov study NCT05691465. IPD Sharing: YES. Countries: 1. Publications: 0.
Data Collection in Lutetium Treated Prostate Cancer: Recording of Progression and Tumor Characteristics
ClinicalTrials.gov study NCT06260410. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Effectiveness of an Anti-cancer Drug, Triapine, When Used With Targeted Radiation-based Treatment (Lutetium Lu 177 Dotatate), Compared to Lutetium Lu 177 Dotatate Alone for Metastatic Neur
ClinicalTrials.gov study NCT05724108. IPD Sharing: YES. Countries: 1. Publications: 0.
ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC
ClinicalTrials.gov study NCT05682443. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Lutetium [177Lu] BL-ARC001 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors
ClinicalTrials.gov study NCT07232407. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014
ClinicalTrials.gov study NCT01763554. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Application of Lutetium [177Lu]-Catalase in Tumor Radionuclide Therapy
ClinicalTrials.gov study NCT05985278. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
ClinicalTrials.gov study NCT04665739. IPD Sharing: YES. Countries: 1. Publications: 0.
Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer
ClinicalTrials.gov study NCT06850545. IPD Sharing: NO. Countries: 1. Publications: 0.
Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients
ClinicalTrials.gov study NCT04291300. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Clinical Study of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced Neuroendocrine Neoplasms
ClinicalTrials.gov study NCT06398444. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.
ClinicalTrials.gov study NCT05884255. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
ClinicalTrials.gov study NCT06441331. IPD Sharing: NO. Countries: 2. Publications: 0.
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00087191. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.